Pathway of programmed cell death in HeLa cells induced by polymeric anti-cancer drugs

Biomaterials

Volumn 32, Issue 14, 2011, Pages 3637-3646

  Guan, Yan Qing ^a   Li, Zhibin ^a   Chen, Jiamei ^a   Tao, Huimin ^a   Wang, Wenwen ^a   Zheng, Zhe ^a   Li, Ling ^a   Liu, Jun Ming ^a,b,c  

^a SOUTH CHINA NORMAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c INTERNATIONAL CENTRE FOR MATERIALS PHYSICS   (China)

Author keywords

Co immobilized IFN plus TNF ; EndoG; HeLa; Polystyrene material

Indexed keywords

ANTICANCER DRUG; APOPTOSIS; BIOLOGICAL APPLICATIONS; CANCER CELLS; CERVICAL CANCERS; DRUG MODEL; ELECTRON SPECTROSCOPY FOR CHEMICAL ANALYSIS; ENDOG; FLUORESCENCE MEASUREMENTS; HELA; HELA CELL; INHIBITIVE EFFECTS; PHOTOCHEMICAL METHOD; POLYMERIC MATERIAL; PROGRAMMED CELL DEATHS; RESEARCH AREAS; TUMOR NECROSIS FACTORS; UV ABSORPTION SPECTROSCOPY;

ANIMAL CELL CULTURE; ATOMIC FORCE MICROSCOPY; ATOMIC SPECTROSCOPY; BIOLOGICAL MATERIALS; CELL CULTURE; CELL DEATH; CHEMICAL ANALYSIS; DISEASES; ELECTRON SPECTROSCOPY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; FUNCTIONAL MATERIALS; FUNCTIONAL POLYMERS; GLYCOPROTEINS; ION BEAMS; POLYMERS; POLYSTYRENES;

ABSORPTION SPECTROSCOPY;

ANTINEOPLASTIC AGENT; ENDONUCLEASE G; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ATOMIC FORCE MICROSCOPY; CELL ADHESION; CELL NUCLEUS; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; ELECTRON SPECTROSCOPY; FEMALE; FLUORESCENCE ANALYSIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFRARED SPECTROSCOPY; PHOTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION; SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; POLYMERASE CHAIN REACTION; POLYMERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952104520     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.060     Document Type: Article

References (42)

1. Matsuda T., Sugawara T. Development of a novel protein fixation method with micron-order precision. Langmuir 1995, 11(6):2267-2271.
2. Ohno K., Kayama Y., Ladmiral V., Fukuda T., Tsujii Y. A versatile method of initiator fixation for surface-initiated living radical polymerization on polymeric substrates. Macromolecules 2010, 43(13):5569-5574.
3. Ito Y., Hasuda H., Yamauchi T., Yamauchi T., Komatsu N., Ikebuchi K. Immobilization of erythropoietin to culture erythropoietin-dependent human leukemia cell line. Biomaterials 2004, 25(12):2293-2298.
4. Kang I.K., Kim G.J., Kwon O.H., Ito Y. Co-culture of hepatocytes and fibroblasts by micropatterned immobilization of β-galactose derivatives. Biomaterials 2004, 25(18):4225-4232.
5. Chen G.P., Kawazoe N.K., Fan Y.J., Ito Y., Tateish T. Grid pattern of nanothick microgel network. Langmuir 2007, 23(11):5864-5867.
6. Leist M., Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Cell Biol 2001, 2(8):589-598.
7. Jäättelä M., Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 2003, 4(5):416-423.
8. Dalla V.L., Marini A.M., Salerno S., La Motta C., Condello M., Arancia G., et al. Synthesis and biological activity of 1, 4-dihydrobenzothiopyrano [4, 3-c] pyrazole derivatives, novel pro-apoptotic mitochondrial targeted agents. Bioorg Med Chem 2009, 17(1):326-336.
9. Aggarwal B.B., Eessalu T.E., Hass P.E. Characterization of receptors for human tumor necrosis factor and their regulation by r-interferon. Nature 1985, 318(6047):665-667.
10. Yarden A., Kimchi A. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells. Science 1986, 234(4782):1419-1421.
11. Li J.H., Pober J.S. The cathepsin B death pathway contributes to TNF plus IFN-{gamma}-mediated human endothelial injury. J Immunol 2005, 175(3):1858-1866.
12. Guan Y.Q., He L.M., Cai S.M., Zhou T.H. Anti-cervix-cancer effect of the co-immobilized tumor necrosis factor-α and interferon-γ. J Mater Sci Tech 2006, 22(2):200-204.
13. Guan Y.Q., Li Z.B., Liu J.M. Death signal transduction induced by co-immobilized TNF-α plus IFN-γ and the development of polymeric anti-cancer drugs. Biomaterials 2010, 31(34):9074-9085.
14. Beyaert R., Vanhaesebroeck B., Heyninck K., Boone E., De V.D., Schulze-Osthoff K., et al. Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine. Cancer Res 1993, 53(11):2623-2630.
15. Suk K., Chang I., Kim Y.H., Kim S.S., Kim J.Y., Kim H., et al. Interferon-gamma (IFN gamma) and tumor necrosis factor-alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFN gamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 2001, 276(16):13153-13159.
16. Thomas M., Finnegan C.E., Rogers K.M.A., Purcell J.M., Trimble A., Johnston P.G., et al. STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res 2004, 64(22):8357-8364.
17. Buckley N.E., Hosey A.M., Gorski J.J., Purcell J.W., Mulligan J.M., Harkin D.P., et al. BRCA1 regulates IFN-{gamma} signaling through a mechanism involving the type I IFNs. Mol Cancer Res 2007, 5(3):261-270.
18. Hayashi T., Ishida Y., Kimura K., Iwakura Y., Mukaida N., Kondo T. IFN-{gamma} protects cerulein-induced acute pancreatitis by repressing NF-{kappa}B activation. J Immunol 2007, 178(11):7385-7394.
19. Tliba O., Amranl Y. Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways. Proc Am Thorac Soc 2008, 5(1):106-112.
20. Lin M.L., Lu Y.C., Chung J.G., Li Y.C., Wang S.G., NG S.H., et al. Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway. Cancer Lett 2010, 291(1):46-58.
21. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., et al. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res 2003, 63(24):8977-8983.
22. Bae Y., Nishiyama N., Fukushima S., Koyama H., Yasuhiro M., Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005, 16(1):122-130.
23. Kataoka K., Nishiyama N., Cabral H. Optimization of (1, 2-diamino-cyclohexane) platinum (II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J Control Release 2007, 121(3):146-155.
24. Lee E.S., Na K., Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 2003, 91(1-2):103-113.
25. Bae Y., Fukushima S., Harada A., Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Chem Int Ed Engl 2003, 42(38):4640-4643.
26. Savic R., Luo L.B., Eisenberg A., Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300(5619):615-618.
27. Lin C.Y., Wu H.Y., Wang P.L., Yuan C.J. Mammalian Ste20-like protein kinase 3 induces a caspase-independent apoptotic pathway. Int J Biochem Cell Biol 2010, 42(1):98-105.
28. Zhang W.G., Li D., Mehta J.L. Role of AIF in human coronary artery endothelial cell apoptosis. Am J Physiol Heart Circ Physiol 2004, 286(1):H354-H358.
29. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281(5381):1322-1326.
30. Willis S.N., Fletcher J.I., Kaufmann T., Delft M.F., Chen L., Czabotar P.E., et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007, 315(5813):856-859.
31. Aylon Y., Oren M. Living with p53, dying of p53. Cell 2007, 130(4):597-600.
32. Cano C.E., Gommeaux J., Pietri S., Culcasi M., Garcia S., Seux M. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 2009, 69(1):219-226.
33. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299.
34. Salvesen G.S., Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 1997, 91(4):443-446.
35. Fuentes-Prior P., Salvesen G.S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004, 384(Pt 2):201-232.
36. Zong W.X., Thompson C.B. Necrotic death as a cell fate. Genes Dev 2006, 20(1):1-15.
37. Yoshimori T. Autophagy: paying charon's toll. Cell 2007, 128(5):833-836.
38. Candé C., Cecconi F., Dessen P., Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?. J Cell Sci 2002, 115(24):4727-4734.
39. Li L.Y., Luo X., Wang X.D. Endonuclease G (EndoG) is an apoptotic DNase when released from Mitochondria. Nature 2001, 412(6842):95-99.
40. Zhang Z.F., Yang X.F., Zhang S., Ma X.L., Kong J.M. BNIP3 upregulation and EndoG translocation in delayed neuronal death in stroke and in hypoxia. Stroke 2007, 38(5):1606-1613.
41. Buttner S., Eisenberg T., Carmona-Gutierrez D., Ruli D., Knauer H., Ruckenstuhl C., et al. Endonuclease g regulates budding yeast life and death. Mol Cell 2007, 25(2):233-246.
42. Russo M., Mupo A., Spagnuolo C., Russo G.L. Exploring death receptor pathways as selective targets in cancer therapy. Biochem Pharmacol 2010, 80(5):674-682.